Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes

Journal of Neuroscience

Volumn 34, Issue 3, 2014, Pages 726-736

  Aung, Moe H ^a,b,c   na Park, Han ^b,c   Han, Moon K ^b,c   Obertone, Tracy S ^b,c   Abey, Jane ^b   Aseem, Fazila ^b   Thule, Peter M ^a,c   Michael Iuvone, P ^a,b   Pardue, Machelle T ^a,b,c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Diabetic retinopathy; Dopamine; Visual function

Indexed keywords

DOPAMINE; GLUCOSE; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTRAST SENSITIVITY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPATIAL FREQUENCY DISCRIMINATION; VISION; VISUAL DISORDER;

DIABETIC RETINOPATHY; DOPAMINE; VISUAL FUNCTION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; LEVODOPA; MALE; MICE; MICE, KNOCKOUT; RATS; RATS, LONG-EVANS; RETINA;

EID: 84892425127     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3483-13.2014     Document Type: Article

References (76)

1. Abu El-Asrar AM, Dralands L, Missotten L, Geboes K (2007) Expression of antiapoptotic and proapoptotic molecules in diabetic retinas. Eye (Lond) 21:238-245. CrossRef Medline
2. Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K (2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 45:2760-2766. CrossRef Medline
3. Aguiar AS Jr, Moreira EL, Hoeller AA, Oliveira PA, Córdova FM, Glaser V, Walz R, Cunha RA, Leal RB, Latini A, Prediger RD (2013) Exercise attenuates levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned mice. Neuroscience 243:46-53. CrossRef Medline
4. Akimov NP, Rentería RC (2012) Spatial frequency threshold and contrast sensitivity of an optomotor behavior are impaired in the Ins2Akita mouse model of diabetes. Behav Brain Res 226:601-605. CrossRef Medline
5. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA, Simpson IA (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55: 2401-2411. CrossRef Medline
6. Atkinson CL, Feng J, Zhang DQ (2013) Functional integrity and modification of retinal dopaminergic neurons in the rd1 mutant mouse: roles of melanopsin and GABA. J Neurophysiol 109:1589-1599. CrossRef Medline
7. Aung MH, Kim MK, Olson DE, Thule PM, Pardue MT (2013) Early visual deficits in streptozotocin-induced diabetic Long-Evans rats. Invest Ophthalmol Vis Sci 54:1370-1377. CrossRef Medline
8. Barber AJ (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 27:283-290. CrossRef Medline
9. Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52:1156-1163. CrossRef Medline
10. Bhatwadekar AD, Yan Y, Qi X, Thinschmidt JS, Neu MB, Li Calzi S, Shaw LC, Dominiguez JM, Busik JV, Lee C, Boulton ME, Grant MB (2013) Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow. Diabetes 62:273-282. CrossRef Medline
11. Björklund A, Dunnett SB (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci 30:194-202. CrossRef Medline
12. Bloomfield SA, Völgyi B (2009) The diverse functional roles and regulation of neuronal gap junctions in the retina. Nat Rev Neurosci 10:495-506. CrossRef Medline
13. Bodis-Wollner I (2009) Retinopathy in Parkinson Disease. J Neural Transm 116:1493-1501. CrossRef Medline
14. Brandies R, Yehuda S (2008) The possible role of retinal dopaminergic system in visual performance. Neurosci Biobehav Rev 32:611-656. CrossRef Medline
15. Busik JV, Tikhonenko M, Bhatwadekar A, Opreanu M, Yakubova N, Caballero S, Player D, Nakagawa T, Afzal A, Kielczewski J, Sochacki A, Hasty S, Li Calzi S, Kim S, Duclas SK, Segal MS, Guberski DL, Esselman WJ, Boulton ME, Grant MB (2009) Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med 206:2897-2906. CrossRef Medline
16. Cai J, BoultonM (2002) The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye (Lond) 16:242-260. CrossRef Medline
17. Cao X, Yasuda T, Uthayathas S, Watts RL, Mouradian MM, Mochizuki H, Papa SM (2010) Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements. J Neurosci 30:7335-7343. CrossRef Medline
18. Clee SM, Attie AD (2007) The genetic landscape of type 2 diabetes in mice. Endocr Rev 28:48-83. CrossRef Medline
19. Congdon NG, Friedman DS, Lietman T (2003) Important causes of visual impairment in the world today. JAMA 290:2057-2060. CrossRef Medline
20. do Carmo Buonfiglio D, Peliciari-Garcia RA, do Amaral FG, Peres R, Nogueira TC, Afeche SC, Cipolla-Neto J (2011) Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats. Invest Ophthalmol Vis Sci 52:7416-7422. CrossRef Medline
21. Doi M (2012) Circadian clock-deficient mice as a tool for exploring disease etiology. Biol Pharm Bull 35:1385-1391. CrossRef Medline
22. Douglas RM, Alam NM, Silver BD, McGill TJ, Tschetter WW, Prusky GT (2005) Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system. Vis Neurosci 22:677-684. CrossRef Medline
23. Doyle SE, McIvor WE, Menaker M (2002) Circadian rhythmicity in dopamine content of mammalian retina: role of the photoreceptors. J Neurochem 83:211-219. CrossRef Medline
24. Fernstrom JD, Fernstrom MH (2007) Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr 137:1539S-1547S; discussion 1548S. Medline
25. Fernstrom MH, Volk EA, Fernstrom JD (1984) In vivo tyrosine hydroxylation in the diabetic rat retina: effect of tyrosine administration. Brain Res 298:167-170. CrossRef Medline
26. Fernstrom MH, Volk EA, Fernstrom JD, Iuvone PM (1986) Effect of tyrosine administration on dopa accumulation in light-and dark-adapted retinas from normal and diabetic rats. Life Sci 39:2049-2057. CrossRef Medline
27. Fletcher EL, Phipps JA, WardMM, Puthussery T, Wilkinson-Berka JL (2007) Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Des 13:2699-2712. CrossRef Medline
28. Frank RN (2004) Diabetic retinopathy. N Engl J Med 350:48-58. CrossRef Medline
29. Gastinger MJ, Singh RS, Barber AJ (2006) Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akitadiabetic mouse retinas. Invest Ophthalmol Vis Sci 47:3143-3150. CrossRef Medline
30. Ghirlanda G, Di Leo MA, Caputo S, Cercone S, Greco AV (1997) From functional to microvascular abnormalities in early diabetic retinopathy. Diabetes Metab Rev 13:15-35. CrossRef Medline
31. Herichová I, Zeman M, Stebelová K, Ravingerová T (2005) Effect of streptozotocin-induced diabetes on daily expression of per2 and dbp in the heart and liver and melatonin rhythm in the pineal gland of Wistar rat. Mol Cell Biochem 270:223-229. CrossRef Medline
32. Herrmann R, Heflin SJ, Hammond T, Lee B, Wang J, Gainetdinov RR, Caron MGG, Eggers ED, Frishman LJ, McCall MA, Arshavsky VY (2011) Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. Neuron 72:101-110. CrossRef Medline
33. Hikichi T, Tateda N, Miura T (2011) Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. Clin Ophthalmol 5:655-660. CrossRef Medline
34. Iuvone PM, Galli CL, Garrison-Gund CK, Neff NH (1978) Light stimulates tyrosine hydroxylase activity and dopamine synthesis in retinal amacrine neurons. Science 202:901-902. CrossRef Medline
35. 4 receptor activation controls circadian timing of the adenylyl cyclase 1/cyclic AMP signaling system in mouse retina. Eur J Neurosci 34:57-64. CrossRef Medline
36. Jackson CR, Ruan GX, Aseem F, Abey J, Gamble K, Stanwood G, Palmiter RD, Iuvone PM, McMahon DG (2012) Retinal dopamine mediates multiple dimensions of light-adapted vision. J Neurosci 32:9359-9368. CrossRef Medline
37. Jackson DM, Ross SB, HashizumeM (1988) Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice. Psychopharmacology (Berl) 94:321-327. Medline
38. Jackson GR, Barber AJ (2010) Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep 10:380-384. CrossRef Medline
39. Kashii S, Takahashi M, Mandai M, Shimizu H, Honda Y, Sasa M, Ujihara H, Tamura Y, Yokota T, Akaike A (1994) Protective action of dopamine against glutamate neurotoxicity in the retina. Invest Ophthalmol Vis Sci 35:685-695. Medline
40. Kern TS, Barber AJ (2008) Retinal ganglion cells in diabetes. J Physiol 586: 4401-4408. CrossRef Medline
41. Kern TS, Miller CM, Tang J, Du Y, Ball SL, Berti-Matera L (2010a) Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop. Mol Vis 16:1629-1639. Medline
42. Kern TS, Tang J, Berkowitz BA (2010b) Validation of structural and functional lesions of diabetic retinopathy in mice. Mol Vis 16:2121-2131. Medline
43. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431. CrossRef Medline
44. Kirwin SJ, Kanaly ST, Linke NA, Edelman JL (2009) Strain-dependent increases in retinal inflammatory proteins and photoreceptor FGF-2 expression in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 50:5396-5404. CrossRef Medline
45. Kirwin SJ, Kanaly ST, Hansen CR, Cairns BJ, Ren M, Edelman JL (2011) Retinal gene expression and visually evoked behavior in diabetic Long-Evans rats. Invest Ophthalmol Vis Sci 52:7654-7663. CrossRef Medline
46. Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179-183. CrossRef Medline
47. Kowluru RA (2005) Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal 7:1581-1587. CrossRef Medline
48. Kowluru RA, Chan PS (2007) Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007:43603. Medline
49. 1 dopamine receptor agonist, SKF83959, attenuates hydrogen peroxide-induced injury in RGC-5 cells involving the extracellular signal-regulated kinase/p38 pathways. Mol Vis 18:2882-2895. Medline
50. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25:402-408. CrossRef Medline
51. Mao J, Liu S, Qin W, Li F, Wu X, Tan Q (2010) Levodopa inhibits the development of form-deprivation myopia in guinea pigs. Optom Vis Sci 87:53-60. CrossRef Medline
52. Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, Ko CH, Ivanova G, Omura C, Mo S, Vitaterna MH, Lopez JP, Philipson LH, Bradfield CA, Crosby SD, JeBailey L, Wang X, Takahashi JS, Bass J (2010) Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 466:627-631. CrossRef Medline
53. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330-3336. CrossRef Medline
54. Moreland RB, Patel M, Hsieh GC, Wetter JM, Marsh K, Brioni JD (2005) A-412997 is a selective dopamine D4 receptor agonist in rats. Pharmacol Biochem Behav 82:140-147. CrossRef Medline
55. Muir ER, Rentería RC, Duong TQ (2012) Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes. Invest Ophthalmol Vis Sci 53:6488-6494. CrossRef Medline
56. Nir I, Iuvone PM (1994) Alterations in light-evoked dopamine metabolism in dystrophic retinas of mutant rds mice. Brain Res 649:85-94. CrossRef Medline
57. Nir I, Haque R, Iuvone PM (2000) Diurnal metabolism of dopamine in the mouse retina. Brain Res 870:118-125. CrossRef Medline
58. Nishimura C, Kuriyama K (1985) Alterations in the retinal dopaminergic neuronal system in rats with streptozotocin-induced diabetes. J Neurochem 45:448-455. CrossRef Medline
59. Northington FK, Hamill RW, Banerjee SP (1985) Dopamine-stimulated adenylate cyclase and tyrosine hydroxylase in diabetic rat retina. Brain Res 337:151-154. CrossRef Medline
60. Obrosova IG, Chung SS, Kador PF (2010) Diabetic cataracts: mechanisms and management. Diabetes Metab Res Rev 26:172-180. CrossRef Medline
61. Pozdeyev N, Tosini G, Li L, Ali F, Rozov S, Lee RH, Iuvone PM (2008) Dopamine modulates diurnal and circadian rhythms of protein phosphorylation in photoreceptor cells of mouse retina. Eur J Neurosci 27: 2691-2700. CrossRef Medline
62. Prusky GT, Alam NM, DouglasRM (2006) Enhancement of vision by monocular deprivation in adult mice. J Neurosci 26:11554-11561. CrossRef Medline
63. Puk O, Dalke C, Hrabé de Angelis M, Graw J (2008) Variation of the response to the optokinetic drum among various strains of mice. Front Biosci 13:6269-6275. Medline
64. Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS (2012) Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech 5:444-456. CrossRef Medline
65. Sasaki M, Ozawa Y, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K (2010) Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 53:971-979. CrossRef Medline
66. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108. CrossRef Medline
67. Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, Ikeda K, Abe H, Takei N (2004) Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53:2412-2419. CrossRef Medline
68. Shirao Y, Kawasaki K (1998) Electrical Responses from Diabetic Retina. Prog Retin Eye Res 17:59-76. CrossRef Medline
69. Thulé PM, Campbell AG, Kleinhenz DJ, Olson DE, Boutwell JJ, Sutliff RL, Hart CM (2006) Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats. Am J Physiol Endocrinol Metab 290:E114-E122. Medline
70. Tosini G, Baba K, Hwang CK, Iuvone PM (2012) Melatonin: an underappreciated player in retinal physiology and pathophysiology. Exp Eye Res 103:82-89. CrossRef Medline
71. Trulson ME, Himmel CD (1983) Decreased brain dopamine synthesis rate and increased (3H)spiroperidol binding in streptozotocin-diabetic rats. J Neurochem 40:1456-1459. CrossRef Medline
72. Turner PV, Albassam MA (2005) Susceptibility of rats to corneal lesions after injectable anesthesia. Comp Med 55:175-182. Medline
73. Villarroel M, Ciudin A, Hernández C, SimóR (2010) Neurodegeneration: An early event of diabetic retinopathy. World J Diabetes 1:57-64. CrossRef Medline
74. Witkovsky P (2004) Dopamine and retinal function. Doc Ophthalmol 108: 17-40. CrossRef Medline
75. Yamauchi T, Kashii S, Yasuyoshi H, Zhang S, Honda Y, Ujihara H, Akaike A (2003) Inhibition of glutamate-induced nitric oxide synthase activation by dopamine in cultured rat retinal neurons. Neurosci Lett 347:155-158. CrossRef Medline
76. Young ME, Wilson CR, Razeghi P, Guthrie PH, Taegtmeyer H (2002) Alterations of the circadian clock in the heart by streptozotocin-induced diabetes. J Mol Cell Cardiol 34:223-231. CrossRef Medline